Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-11-04Clinical Trial Update: Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection [Phase 1]
A Phase 1 pilot trial assessing the safety and pharmacology of ezetimibe for chronic hepatitis C virus infection. The current trial status i…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects [Phase 3]
This document reports the completion of the Phase 3 UNITY 1 trial evaluating a fixed-dose combination of daclatasvir, asunaprevir, and BMS-7…
-
CLINICAL_TRIALS trial_result · 2015-11-03Clinical Trial Update: Adherence in Patients Receiving PegIntron and Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04206)
A terminated clinical trial update reports adherence data for patients with chronic hepatitis C treated with PegIntron and Rebetol under a p…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3) [Phase 3]
Phase 3 STARTverso 3 trial evaluated faldaprevir in combination with pegylated interferon-alfa and ribavirin in treatment-experienced genoty…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy
A clinical trial update examining viral load changes in lymphoma patients with hepatitis C infection after chemotherapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection. [Phase 3]
Phase 3 trial evaluating the combination of daclatasvir and sofosbuvir for HIV and hepatitis C coinfection; the study has completed and resu…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care [Phase 2]
A Phase 2 study by Bristol-Myers Squibb evaluating an antiviral combination therapy for chronic hepatitis C in patients who had not received…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients [Phase 2]
A Phase 2 trial evaluating the addition of daclatasvir to standard of care in treatment-naïve hepatitis C patients. The study is completed a…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha and Ribavirin) [Phase 2]
A Phase 2 trial evaluated daclatasvir (BMS-790052) in combination with standard of care for hepatitis C; the study completed and results wer…
-
CLINICAL_TRIALS withdrawal · 2015-10-22Clinical Trial Update: Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN) [Phase 2]
A Phase 2 trial evaluating regimens of vaniprevir (MK7009) for treatment-naive patients with chronic genotype 1 hepatitis C virus infection …
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant [Phase 3]
Phase III trial update evaluating daclatasvir + sofosbuvir + ribavirin in cirrhotic Hepatitis C patients and those post-liver transplant. Re…
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: "Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study" [Phase 4]
A Phase 4 pilot study completed that evaluated the pharmacoeconomic aspects of autophagy inhibition in hepatitis C patients resistant to sta…
-
CLINICAL_TRIALS trial_result · 2015-10-19Clinical Trial Update: Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients [Phase 3]
Phase 3 clinical trial evaluating asunaprevir and daclatasvir on immune status in chronic hepatitis C patients has completed, with an update…
-
CLINICAL_TRIALS research · 2015-10-16Clinical Trial Update: ADHEPTA Study: Adherence Questionnaire in Hepatitis C
The ADHEPTA study evaluating an adherence questionnaire in people with chronic hepatitis C has completed. The study includes participants wi…
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: An Integrated Care Model for Improving Hepatitis C Virus Patient Outcomes [NA]
This completed clinical trial evaluates an integrated care model to improve outcomes for patients with Hepatitis C. Results have been posted…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: A Multiple Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Genotype 1 Infected Subjects [Phase 2]
A Phase 2 multiple ascending-dose study of daclatasvir (BMS-790052) in hepatitis C genotype 1–infected subjects has completed, with results …
-
CLINICAL_TRIALS research · 2015-10-14Clinical Trial Update: Identification of Viral Variants Involved in the Transmission of Hepatitis C and Characterization of Antigenic and Functional Properties of Their Envelope Glycoproteins [NA]
A completed clinical trial update reporting the identification of hepatitis C virus variants involved in transmission and characterization o…
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066) [Phase 3]
A Phase 3 trial comparing grazoprevir/elbasvir to boceprevir-based therapy for chronic hepatitis C was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-10-14Clinical Trial Update: Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022) [Phase 1]
A Phase 1 clinical trial evaluating the hepatic pharmacokinetics of Grazoprevir (MK-5172) in participants with chronic hepatitis C has been …
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Safety and Efficacy of Daclatasvir (BMS-790052) Plus Standard of Care (Pegylated-interferon Alpha-2b and Ribavirin) in Japanese Patients [Phase 2]
Phase 2 trial evaluating safety and efficacy of daclatasvir (BMS-790052) plus pegylated interferon alfa-2b and ribavirin in Japanese patient…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment [Phase 2]
Phase 2 study of BMS-790052 (daclatasvir) combined with pegylated interferon and ribavirin in patients who failed prior hepatitis C treatmen…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care [Phase 2]
A Phase 2 study sponsored by Bristol-Myers Squibb evaluated an antiviral combination for chronic hepatitis C in patients who previously fail…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects [Phase 3]
A Phase 3 trial comparing asunaprevir plus daclatasvir versus telaprevir in Japanese patients with hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin [Phase 2]
A Phase 2 study evaluated BMS-650032 in combination with peginterferon alfa-2a and ribavirin for hepatitis C. The trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) Subject [Phase 2]
A Phase 2 antiviral combination trial in Japanese patients with Hepatitis C has completed.